Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study.
This study investigated the serotonergic modulation of face emotion processing using blood oxygen level-dependent (BOLD) functional MRI. In a placebo-controlled, balanced order design, intravenous citalopram (7.5 mg) was given to 12 male volunteers 60 min before a covert face emotion recognition task. Angry, disgusted and fearful faces produced BOLD signal responses, which were broadly consistent with previous findings. Citalopram enhanced the BOLD signal response in the left posterior insula (together with nonprespecified pulvinar and visual cortex) but attenuated activation in the left amygdala to disgusted faces and right amygdala activation to fearful faces. No citalopram modulation of BOLD responses to angry faces were found. These results suggest that serotonin modulates low-level amygdala activation to aversive stimuli.
Anderson
Ian M
IM
Neuroscience and Psychiatry Unit, The University of Manchester, Stopford Building, Oxford Road, Manchester, UK. ian.anderson@manchester.ac.uk
Del-Ben
Cristina M
CM
Mckie
Shane
S
Richardson
Paul
P
Williams
Stephen R
SR
Elliott
Rebecca
R
Deakin
J F William
JF
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D001921:Brain / Q000098:blood supply / Q000187:drug effects* / Q000502:physiology; D001931:Brain Mapping; D015283:Citalopram / Q000494:pharmacology*; D004644:Emotions / Q000187:drug effects* / Q000502:physiology; D005145:Face; D007839:Functional Laterality; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D010100:Oxygen / Q000097:blood; D010364:Pattern Recognition, Visual / Q000187:drug effects / Q000502:physiology; D010775:Photic Stimulation / Q000379:methods; D016037:Single-Blind Method
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D010100:Oxygen